semaglutide vs tirzepatide nausea Weight Loss Dynamics and Health Burden Changes with versus Tirzepatide vs Semaglutide: Weight Loss

Figure 1 FAERS is a publicly available and anonymous database

Many people at 15 mg report needing to set reminders to eat, as natural hunger signals become significantly diminished

Pre-bed dosing helps by timing the pulse to sleep rather than active hours

In contrast, Mounjaros active ingredient, tirzepatide, targets GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors

A wide variety of medications can cause weight gain, and many of them are not related to breast cancer

According to the Summary of Product Characteristics (SmPC), the most commonly reported adverse effects are gastrointestinal in nature and include nausea (reported in up to 24% of patients), diarrhoea (up to 18%), vomiting (up to 13%), and constipation (up to 12%)